These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 9112254)

  • 21. Critical role of poly(ADP-ribose) polymerase-1 in modulating the mode of cell death caused by continuous oxidative stress.
    Son YO; Kook SH; Jang YS; Shi X; Lee JC
    J Cell Biochem; 2009 Nov; 108(4):989-97. PubMed ID: 19711368
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Poly(ADP-ribose) polymerase mediates the suicide response to massive DNA damage: studies in normal and DNA-repair defective cells.
    Berger NA; Sims JL; Catino DM; Berger SJ
    Princess Takamatsu Symp; 1983; 13():219-26. PubMed ID: 6317637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential protective effects of O-phenanthroline and catalase on H2O2-induced DNA damage and inhibition of protein synthesis in endothelial cells.
    Jornot L; Petersen H; Junod AF
    J Cell Physiol; 1991 Dec; 149(3):408-13. PubMed ID: 1660479
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biochemical modulation of tumor cell energy: regression of advanced spontaneous murine breast tumors with a 5-fluorouracil-containing drug combination.
    Stolfi RL; Colofiore JR; Nord LD; Koutcher JA; Martin DS
    Cancer Res; 1992 Aug; 52(15):4074-81. PubMed ID: 1379119
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adenine nucleotide metabolism and cell fate after oxidant exposure of rat cortical neurons: effects of inhibition of poly(ADP-ribose) polymerase.
    Aito H; Aalto KT; Raivio KO
    Brain Res; 2004 Jul; 1013(1):117-24. PubMed ID: 15196974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ATP depletion + pyrimidine depletion can markedly enhance cancer therapy: fresh insight for a new approach.
    Martin DS; Bertino JR; Koutcher JA
    Cancer Res; 2000 Dec; 60(24):6776-83. PubMed ID: 11156364
    [No Abstract]   [Full Text] [Related]  

  • 27. Poly(ADP-ribose) polymerase-1 in the nervous system.
    Ha HC; Snyder SH
    Neurobiol Dis; 2000 Aug; 7(4):225-39. PubMed ID: 10964595
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Growth inhibition and cell killing by N-methyl-N-nitrosourea: metabolic alterations that accompany poly(ADP-ribosyl)ation.
    Mizumoto K; Farber JL
    Arch Biochem Biophys; 1995 Jun; 319(2):512-8. PubMed ID: 7786036
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of cell death mediated by apoptosis-inducing factor due to the absence of poly(ADP-ribose) glycohydrolase.
    Zhou Y; Feng X; Koh DW
    Biochemistry; 2011 Apr; 50(14):2850-9. PubMed ID: 21366272
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Neuronal death: potential role of the nuclear enzyme, poly (ADP-ribose) polymerase].
    Boulu RG; Mesenge C; Charriaut-Marlangue C; Verrecchia C; Plotkine M
    Bull Acad Natl Med; 2001; 185(3):555-63; discussion 564-5. PubMed ID: 11501263
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neither energy collapse nor transcription underlie in vitro neurotoxicity of poly(ADP-ribose) polymerase hyper-activation.
    Fossati S; Cipriani G; Moroni F; Chiarugi A
    Neurochem Int; 2007 Jan; 50(1):203-10. PubMed ID: 17052800
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanisms of lymphocytotoxicity induced by extracorporeal photochemotherapy for cutaneous T cell lymphoma.
    Marks DI; Rockman SP; Oziemski MA; Fox RM
    J Clin Invest; 1990 Dec; 86(6):2080-5. PubMed ID: 2123891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blockade of PARP activity attenuates poly(ADP-ribosyl)ation but offers only partial neuroprotection against NMDA-induced cell death in the rat retina.
    Goebel DJ; Winkler BS
    J Neurochem; 2006 Sep; 98(6):1732-45. PubMed ID: 16903875
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bcl-2 prevents topoisomerase II inhibitor GL331-induced apoptosis is mediated by down-regulation of poly(ADP-ribose)polymerase activity.
    Kuo ML; Shen SC; Yang CH; Chuang SE; Cheng AL; Huang TS
    Oncogene; 1998 Oct; 17(17):2225-34. PubMed ID: 9811453
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of the enzymatic catalysis of poly(ADP-ribose) polymerase by dsDNA, polyamines, Mg2+, Ca2+, histones H1 and H3, and ATP.
    Kun E; Kirsten E; Mendeleyev J; Ordahl CP
    Biochemistry; 2004 Jan; 43(1):210-6. PubMed ID: 14705947
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Poly(ADP-ribose): PARadigms and PARadoxes.
    Bürkle A; Virág L
    Mol Aspects Med; 2013 Dec; 34(6):1046-65. PubMed ID: 23290998
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation of retention of tumor methylmercaptopurine riboside-5'-phosphate with effectiveness in CD8F1 murine mammary tumor regression.
    Nord LD; Stolfi RL; Colofiore JR; Martin DS
    Biochem Pharmacol; 1996 Mar; 51(5):621-7. PubMed ID: 8615898
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhancement of chemotherapeutically-induced apoptosis in vivo by biochemical modulation of poly (ADP-ribose) polymerase.
    Martin D; Stolfi R; Nord L; Colofiore J
    Oncol Rep; 1996 Mar; 3(2):317-22. PubMed ID: 21594366
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A concomitant ATP-depleting strategy markedly enhances anticancer agent activity.
    Martin DS; Spriggs D; Koutcher JA
    Apoptosis; 2001; 6(1-2):125-31. PubMed ID: 11321035
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Review article: manipulation of cell death--the development of novel strategies for the treatment of gastrointestinal disease.
    Watson AJ
    Aliment Pharmacol Ther; 1995 Jun; 9(3):215-26. PubMed ID: 7654884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.